Acumen Hypotension Prediction Index (HPI) Feature Software vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

These two tools are adjacent in their application of AI within cardiology but serve distinct clinical purposes. Tool A is designed for proactive hemodynamic management by predicting hypotensive events, primarily benefiting critical care and anesthesiology. Tool B, conversely, assists electrophysiologists in real-time during cardiac ablation procedures by identifying abnormal electrograms to improve treatment efficacy for arrhythmias.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your primary goal is proactive management of hemodynamic instability, specifically preventing hypotensive events. This tool is ideal for critical care or surgical settings where continuous monitoring and early intervention for blood pressure fluctuations can significantly improve patient outcomes by reducing the incidence and severity of hypotension.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or tachycardia and require real-time, AI-assisted identification of abnormal electrograms. This software is best suited for enhancing the precision of ablation by highlighting spatio-temporal dispersed electrograms, thereby potentially improving the efficacy and success rates of complex arrhythmia treatments.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software VX1+
Deployment Unknown Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is seamlessly integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, providing a cohesive user experience within a familiar ecosystem. An FDA-mandated usability study confirmed its effectiveness, and its continuous, real-time updates with clear alerts facilitate proactive clinical management.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI has demonstrated a significant reduction in the incidence, duration, and severity of intraoperative hypotension, and is associated with reduced risks of acute kidney injury and myocardial injury. Its predictive capability up to 15 minutes before an event offers a crucial window for intervention across various critical care settings.

Pricing & Value

Tie

Both tools have opaque pricing, requiring direct contact with the vendor for specific cost information. While some associated hardware costs for Acumen HPI are publicly known, there is no clear evidence of direct cost savings from either software, making a definitive value comparison impossible.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI benefits from being developed by Edwards Lifesciences, a large and established medical technology company with a global presence, robust enterprise infrastructure, and explicit HIPAA compliance and BAA availability. This indicates a strong foundation for enterprise deployment and support. [JSON, cite: 19, 20, 21, 23, 25, 26]

Innovation

Tie

Both tools represent significant innovations in their respective domains. Acumen HPI's predictive analytics for hypotension, offering a 15-minute warning, is a groundbreaking advancement. VX1+'s real-time AI-driven guidance for identifying dispersed electrograms during complex cardiac ablation procedures is a first-of-its-kind in interventional EP, aiming to standardize and improve outcomes. [JSON, cite: 9, 10, 33]

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

Edwards Lifesciences, as a large and established medical device company, explicitly advertises 24/7 technical support and a comprehensive suite of customer service and educational resources for Acumen HPI. While Volta Medical provides a user manual, the breadth and explicit commitment to support are not as clearly articulated as for Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software VX1+
Name Acumen Hypotension Prediction Index (HPI) Feature Software VX1+
Company Edwards Lifesciences Volta Medical
Description Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Categories Cardiology AI, Triage & ER/ICU AI Cardiology AI, Surgical AI
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Key Features Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen for impending hypotensive events, Relationship View screen providing insights into preload, afterload, and contractility, Machine learning algorithms for predictive analysis of blood pressure waveforms, Predicts hypotension up to 15 minutes before an event, Demonstrated reduction in incidence, duration, and severity of intraoperative hypotension, Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring, Adjustable Mean Arterial Pressure (MAP) target for hypotension definition Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart, Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, AI-driven insights to assist electrophysiologists during ablation procedures, Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system), Non-sterile reusable medical device, Simple user interface with color coding for electrogram dispersion (blue, orange, red), Booster mode for increased sensitivity during AT or slow AF, Provides cycle length estimation from electrograms

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is a predictive monitoring tool for anesthesiology, critical care, and emergency medicine, designed to detect and alert clinicians to the likelihood of a hypotensive event before it occurs. VX1+ is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia, primarily for cardiology specialists.
Acumen HPI is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform. VX1+ is a software application on a computing platform that integrates with existing EP recording and 3D mapping systems, including specific Boston Scientific, GE HealthCare, and Abbott systems.
Acumen HPI uses machine learning algorithms to analyze blood pressure waveforms from both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. VX1+ analyzes electrograms to identify spatio-temporal dispersed electrograms (DEs) during atrial fibrillation and atrial tachycardia procedures.
Acumen HPI provides a Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts for impending hypotensive events, and a Relationship View screen offering insights into preload, afterload, and contractility. VX1+ offers real-time manual or automatic annotation of 3D anatomical and electrical maps, identification of DEs, and AI-driven insights to assist electrophysiologists during ablation procedures.
Acumen HPI has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. VX1+ assists operators in the real-time identification of specific abnormal electrograms during AF and AT procedures, with studies showing it can standardize electrogram analysis.
Acumen HPI is compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring and is integrated into the Edwards Lifesciences HemoSphere platform. VX1+ is compatible with existing 510(k)-cleared catheters and specific data acquisition systems such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
Yes, the Mean Arterial Pressure (MAP) target for hypotension definition in Acumen HPI is adjustable. Clinicians can change the default MAP target of 65 mmHg to 55, 60, 70, 75, 80, or 85 mmHg.
AI Tool Finder
AI-powered search. Results may not be comprehensive.